DO YOU KNOW THE FEELING OF PRODUCT LOSS?

Fortunately, there is a process solution to reduce product loss during fluid management and freeze-thaw logistics.

Single Use Support’s modular, scalable, and vendor-agnostic single-use technologies are your game changer. Discover now!

Regulars

5: EDITOR’S DESK: With great power comes great responsibility.

6: A SMALL DOSE: A brief round-up of some of the latest developments in the industry.

8: PERSPECTIVE ON PHARMA: Synkrato examines how Industry 4.0 is driving pharma manufacturing.

12. FRONT COVER:

Fette Compacting shares its efforts in continuous direct compression through a Quality-by-Design approach.

28: OPINION:

Avantor shares insights on how to solve scale-up and manufacturing challenges in C&GT.

34: TALKING POINTS: Stories to consider and what to look out for in EPM over the coming weeks.

Features

14: LYOPHILISATION: World Courier and Alloga Europe discuss the growing trends for cold chain and cryogenic storage.

16: CONTRACT SERVICES: Wellma explains the winning recipe for successful co-manufacturers.

20: INDUSTRY 4.0: Q&A with Thermo Fisher Scientific on leveraging the power of Pharma 4.0 in biopharma.

32: CLINICAL TRIALS: EPM spoke exclusively to Phesi to learn about the power of AI in navigating big data.

Head Office

Carlton House, Sandpiper Way, Chester Business Park, Chester, CH4 9QE.

Tel. +44 (0)1244 680222

Fax. +44 (0)1244 671074 www.pharmaceuticalmanufacturer.media

Editorial

editor rebekah jordan rebekah.jordan@rapidnews.com publisher duncan wood

PRODUCTION head of studio and production sam hamlyn

Advertising

robert anderton tel: +44 (0)1244 952359 robert.anderton@rapidnews.com vp sales & sales talent

Julie Balmforth julie.balmforth@rapidnews.com

Subscriptions

subscriptions@rapidnews.com qualifying readers Europe - Free, ROW - £249 outside qualifying criteria

UK - FREE, ROW - £249 please subscribe online at www.pharmaceuticalmanufacturer.media

With Great Power Comes Great Responsibility

manufacturers to maintain focus on product quality, whilst optimising their production processes and minimising the risk of costly breakdowns.

On the clinical side of things, investing in digital solutions could see rising recruitment rates and declining attrition rates. More on this in an interesting interview I had with clinical data company, Phesi, (pg. 32) discussing clinical trial metrics over the past year.

Address changes emailed to subscriptions@rapidnews.com

European Pharmaceutical Manufacturer is published by Rapid Life Sciences Ltd. European Pharmaceutical Manufacturer is distributed in electronic and print formats to a combined readership of 14,000 pharmaceutical manufacturing professionals.

Volume 23 Issue 2 Mar/Apr 2023

While every attempt has been made to ensure that the information contained within European Pharmaceutical Manufacturer is accurate, the publisher accepts no liability for information published in error, or for views expressed. All rights for European Pharmaceutical Manufacturer are reserved and reproduction in part or whole without written permission is strictly prohibited.

Pharma is evolving every year, but a big topic that is sticking around is digitalisation. Recently, LogiPharma reported that 86% of pharma and biotech companies planned to be more ‘digitally agile’ over the next 12 months. The main underlying reasons were to develop closer relationships with their suppliers to improve end-to-end visibility, as well as create a more operationally resilient supply chain.

Although on a larger scale, it so happens that some pharma companies are still asking the question: why go digital?

The pharmaceutical industry is often characterised as conservative and slow to adopt new technologies, including digital innovations. Additionally, the complex and highly regulated nature of the industry makes it difficult for companies to quickly implement digital solutions without compromising safety or compliance.

However, the pandemic and ongoing geo-political situations have only exacerbated the need for a more resilient supply chain. It’s shown us that the conventional way of